Johnson & Johnson (JNJ): Price and Financial Metrics

JNJ POWR Grades

• Stability is the dimension where JNJ ranks best; there it ranks ahead of 96.16% of US stocks.
• JNJ's strongest trending metric is Growth; it's been moving down over the last 179 days.
• JNJ ranks lowest in Momentum; there it ranks in the 8th percentile.

JNJ Stock Summary

• JNJ has a higher market value than 99.74% of US stocks; more precisely, its current market capitalization is $467,326,122,403.
• JNJ's went public 36.27 years ago, making it older than 92.84% of listed US stocks we're tracking.
• In terms of volatility of its share price, JNJ is more volatile than only 1.84% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to Johnson & Johnson, a group of peers worth examining would be UNH, JPM, WMT, BHP, and PG.
• JNJ's SEC filings can be seen here. And to visit Johnson & Johnson's official web site, go to www.jnj.com.

JNJ Valuation Summary

• JNJ's EV/EBIT ratio is 23.3; this is 20.48% lower than that of the median Healthcare stock.
• Over the past 243 months, JNJ's price/sales ratio has gone down 1.
• Over the past 243 months, JNJ's price/sales ratio has gone down 1.

Below are key valuation metrics over time for JNJ.

JNJ Growth Metrics

The 5 year cash and equivalents growth rate now stands at 12.04%.
• Its 2 year cash and equivalents growth rate is now at 6.09%.
• Its 3 year price growth rate is now at 23.79%.

JNJ's revenue has moved up $12,919,000,000 over the prior 15 months.

The table below shows JNJ's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	93,775	23,410	20,878
2021-09-30	91,446	26,021	17,880
2021-06-30	89,190	26,114	17,767
2021-03-31	84,214	24,252	15,115
2020-12-31	82,584	23,536	14,714
2020-09-30	80,856	21,591	16,986

JNJ's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• JNJ has a Quality Grade of B, ranking ahead of 92.45% of graded US stocks.
• JNJ's asset turnover comes in at 0.52 -- ranking 78th of 682 Pharmaceutical Products stocks.
• CBIO, CLSD, and ABBV are the stocks whose asset turnover ratios are most correlated with JNJ.

The table below shows JNJ's key quality metrics over time.